Please provide your email address to receive an email when new articles are posted on . Data came from the FDA Adverse Event Reporting System from 2004 to 2024. Omalizumab had significant associations ...
Dear Dr. Roach: You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on data. But I wonder how ...
A landmark Lancet analysis of more than 150,000 trial participants challenges decades of statin side-effect warnings and calls for updated drug labels grounded in randomized evidence. Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results